Pfizer's covid-19 vaccine, China looks at fintech regulation, and Lyft President John Zimmer on the future of gig work

Pivot

Kara and Scott talk about Pfizer's early success with a covid-19 vaccine and how that is effecting the stock market. They also discuss Ant's halted IPO, the repercussions for the company and how China is using the opportunity to look at financial tech regulations. Then we are joined by Friend of Pivot, President and Founder of Lyft, John Zimmer to talk about the passing of Proposition-22 and what it means for app drivers.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

More description

Kara and Scott talk about Pfizer's early success with a covid-19 vaccine and how that is effecting the stock market. They also discuss Ant's halted IPO, the repercussions for the company and how China is using the opportunity to look at financial tech regulations. Then we are joined by Friend of Pivot, President and Founder of Lyft, John Zimmer to talk about the passing of Proposition-22 and what it means for app drivers.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

2020-11-10 63 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.